In the NSAS-BC protocol, the nuclear atypia and mitotic counts are to be judged by pathologists at each participating hospital for assessing high-risk node-negative breast cancers. Therefore, maintenance of interobserver agreement in diagnosis at a higher level is mandatory during the period of patient entry.
INTRODUCTION
A multi-institutional protocol study, named the National Surgical Adjuvant Study of Breast Cancer (NSAS-BC), was initiated in 1995 to compare the effects of two different regimens of surgical adjuvant chemotherapy on node-negative breast cancers (1). To identify higher risk patients, the NSAS-BC pathology section, which is composed of collaborating pathologists, established histopathological criteria comprising histological type and scores for both cancer cell nuclear atypia and the number of mitoses (2) . In general, surgical pathologists participate in clinical protocol studies as central pathological review panels to give a consensus diagnosis based on established criteria. In this protocol, however, we introduced an individualized system in which pathologists at each collaborating hospital diagnose the histological eligibility at their hospital based on the criteria. We did not adopt the central review system because the number of cases to be evaluated for histological eligibility was too large for several panel pathologists to examine in a short period before the adjuvant therapy. It has been arguedthat familiarization with the histologicaltype and nuclearatypia scheme is thebest way to achieveinterobserver agreement (3, 4) . We have repeatedly held slide conference sessions to familiarize pathologists with the scheme and to improve the interobserver agreement level (5) . We have also edited a color atlas of breast cancers judged by the NSAS-BC pathologysection to have representativeor equivocalhistological types and nuclear atypia. Dr Katsushige Yamashiro of the National Sapporo Hospital produced a CD-ROM of the atlas for personal computer. This CD was distributed to all collaborating pathologists. These methods and tools are considered to be effective in standardizing the histological criteria and achieving a higher agreement level in diagnosis among pathologists (5) .
Periodical review of enrolled cases by the panel pathologists and the membersof the pathologysectionwas needed to monitor the reproducibility of the original pathological diagnoses made individually at each hospital. For that purpose, we compared the original diagnosis made for 107 breast cancers at individual hospitals with consensusdiagnosesfrom three panel pathologists and modal diagnoses given by the members of the pathology section at three slide conference sessions.
MATERIALS AND METHODS

ASSIGNMENT OF CONSENSUS AND MODAL DIAGNOSIS FOR ENROLLED CASES
Between October 1996 and February 1998, pathologists at 38 collaborating hospitals made histological diagnoses of 2470 patients with primary breast cancers without lymph node metastasis for histologicaleligibility for the NSAS-BC protocol. They judged 1272 tumors (51.5%) as having a high risk of recurrence based on the histopathological criteria shown in Table 1 (2) . Based on the protocol entry criteria other than histologicalones (1),253 patientswereenrolled.The pathologists selected 107 carcinomas from 23 participating hospitals for this study. Sixty were selected as cases of invasive ductal carcinomas of nuclear atypia score 1, 2 or 3. The other 47 were selected randomly and contained not only invasive ductal carcinomas but also other histologicaltypes.Representative 35 nun transparency photomicrographs of each tumor were taken with xI0, x20 and x40 objective lenses. One histological section which was judged as representativeby the pathologistper case was subjectedfor the review. Twoor three photomicrographs at each case, usually with different magnification, were taken for the review.
For every case,three histological type and nuclearatypia scores were assigned: I, original diagnosis, which the collaborating pathologists at the individual hospitals had assigned for case eligibility;2, consensusdiagnosis, whichthreepanel pathologists (H.T., EA., M.K.) made by total agreement on reviewing the photomicrograph color slides;and 3, modaldiagnosis, which was determinedby majority vote among collaborating pathologistsof the NSAS-BC pathology section.The photomicrograph slides of the 107 tumors were arranged randomly and were presented by slide projector at slide conferences held on 20 September 1997 (30 novel cases), 14 February 1998 (30 previous cases and 30 novel cases), 19September 1998 (47 novel cases and previous 30 cases) and 6 March 1999 (47 previous cases).
The original diagnoses of the invasive ductal carcinomas presented at the first and second conference sessions comprised 20 cases each of nuclear atypia scores 1, 2 and 3. The original diagnoses presented at the third session comprised 35 cases of invasive ductal carcinomas (nuclear atypia score 1 in one, 2 in 23 and 3 in 11), six non-invasive ductal carcinomas, two mucinous carcinomas and one case each of invasive lobular carcinoma, apocrine carcinoma, medullary carcinoma and squamous cell carcinoma. In total and includingthe three panel pathologists, 37 pathologistsparticipatedin the first conference, 29 in the second, 37 in the third and 40 in the fourth; 23 participated in all three conferences (see Appendix). Each pathologist independently assigned histologicaltype and nuclear atypia scores for all cases according to the histopathological criteria After collation of the data, one of the panel pathologists presented the original and consensus diagnoses for each tumor with the photomicrograph slides. At the second, third and fourth conferences, the original, consensusand modal diagnosesfor the previousset of cases were presented again with the photomicrographs. Participants also discussed questionable cases.
STATISTICAL ANALYSIS
To estimate the equality of individual pathologists' original judgments, the original diagnoses were compared with the consensus and modal diagnoses. For the tumor with discordant judgments, the cause of disagreement was analyzed.
The modal nuclear atypia score for each tumor given by the pathologists was calculated and the 'percentage interobserver agreement per tumor' was calculated as (number of observationsthat gave the modal score/numberof all observations)x 100
The strength of agreement was considered high if the percentage interobserver agreement per tumor was >90%, moderate if it was 75-90% and low if it was <75%. A high percentage interobserver agreement per tumor was considered to indicate that the score was close to the 'right answer' for the tumor.In this case, original diagnosis was assumed to be erroneous. A low percentage interobserveragreement per tumor was consideredto indicate the intermediatenature of the tumor,e.g. scores between I and 2 or 2 and 3. In this case, a scoring variation was assumed to be inevitableand the differencebetweenthe originaland modal scoreswas notconsiderederroneous.Witha moderatepercentage interobserver agreement per tumor, the disagreement was considered to derive from multiple factors, including erroneous judgment and intermediatetumor nature. For each conference, the degree of interobserveragreementon histological type and nuclear atypia was tested by using the generalizedK test for more than two observers (6) . In accordance with the criteria of Landis and Koch, the K values were divided into several scales to evaluate the strength of agreement (7) . The strength of agreement was judged as poor 
RESULTS
For the first 30 tumors, the rate of agreement was 67% (20/30) between the original and consensus diagnoses, 73% (22/30) between the original and modal diagnoses and 83% (25/30) between the consensus and modal diagnoses. For the second 30 tumors, the rate of agreement was 67% (20/30) between the original and consensus diagnoses and 73% (22/30) between the original and modal diagnoses, but rose to 93% (28/30) between the consensus and modal diagnoses. For the third 47 tumors, the rate of agreement in both histological type and nuclear atypia score was 72% (34/47) between the original and consensus diagnoses, 79% (37/47) between the original and modal diagnoses and 83% (39/47) between the consensus and modal diagnoses.
The original,consensusand modal diagnoseswere concordant in 7I cases (66%): 60 of 96 invasiveductal carcinomasand all 11 special-type carcinomas. Fig. I shows eight invasive ductal carcinomas for which nuclear atypia scores were concordant among the three diagnoses: Three score I tumors (Fig. 1A-I C) show nuclei uniform in size and shape. The nuclei have an inconspicuouschromatinpattern,but in Fig. IB and IC a reticular or fine granular chromatin pattern and a non-uniform chromatin distribution are also seen. Three score 2 tumors (Fig. ID-IF) have an intermediatedegreeof variationin nuclearsize and shape and the variationis relatively low in Fig. ID but high in Fig. IF . In three score 3 tumors (Fig. IG and IH) , nuclearpolymorphism is conspicuous, chromatin granule condensation shows a coarse and irregular distribution and the nuclei have a vesicular appearance. Large nucleoli are also evident in score 3 tumors.
In 33 of the other 36 invasive ductal carcinomas by modal diagnosis, the nuclear atypia scoresdifferedby only one point. In one invasive ductal carcinoma (case 30), a difference of two points between the original and consensus nuclear atypia scores was seen, but that discrepancy was later found to be due to erroneous identification of the case and not to erroneous scoring. The pathologist who initially diagnosed this tumor agreed that this case was nuclear atypia 3. Thus no tumor had a difference of two points in nuclearatypiascorebetweenthe original,consensus and modal scores. Discordance in histological type was seen in two cases. A case originally diagnosed as apocrine carcinoma (case 85) was revised to invasive ductal carcinoma of nuclear atypia score 2 in the consensusand modal diagnoses. In the other case (104), the originaldiagnosiswas invasiveductal carcinoma, score I, but the consensus diagnosis was non-invasive ductal carcinoma and the modal diagnosiswas invasive ductal carcinoma of nuclear atypia score 2. Further examination of the photomicrographof this case revealeda predominantly intraductal component of cribriform type and a focus of questionably invasive carcinoma with tubular structure.
For the first 30 and second 30 cases, the strength of agreement in nuclear atypia score among observers at the slide conference sessions was moderate, with K values of 0.48 and 0.54, respectively (Tables 2 and 3 ). For the third47 tumors,the strength of the agreementin histologicaltype and nuclearatypia scorewas also moderate, with a 1C value of 0.45. For 36 invasive ductal carcinomasin the third conference,the 1C value for nuclear atypia scores was 0.33. Interobserver agreement in nuclear atypia judgment was maintained at a substantial level, because these K values were similarto valuesof 0.50-0.51 acquiredat the last two of five slide conference sessions held for standardization of the nuclear atypia criteria in the previous study (5) . Because of the high agreementrate betweenthe consensusand modal diagnoses, one of these two was assumed to be the closest to the 'right answer'. Because data for percentage agreement were available for the modal score and that value was applicableto the following analysis, we adopted the modal score as the 'right answer'. (P < 0.005). These25 tumors withlow percentage interobserver agreement were considered to be of intermediate nature, having an equivocal diagnosis. In the other 20 of the former tumors, sevenhadhighpercentage interobserver agreement per tumorfor the modal score, from which the original score differed. Therefore, the original nuclear atypiajudgment of these seven tumors wasconsidered erroneous. In total, the erroneous scoring and typing by the original pathologists wasestimated to be 6.5% (7/1 07). On the assumption that the modal score with high percentage interobserver agreement was the 'right answer', we considered anerroneous judgmentto havebeengiven by onlythe original observers to five tumors and by both original observers and panels to twotumors. In the other 13caseswithdiscordance in judgments, the percentage interobserver agreement per tumor wasmoderate andtheoriginal judgments differed fromthemodal scores. Underlined values: number of observers who gave modal score. Underlined values: number of observers who gave modal score.
Nuclear atypia scoring of breast cancer
DISCUSSION
Most of the original histological type and nuclear atypia scores given by collaborating pathologists at individual hospitals were concordant with the consensus or modal diagnoses. Disagreement in diagnosis of histological type and nuclear atypia score is attributed not only to observers' lack of familiarity with the criteria but also to the intermediate nature of tumors (5) . Thus, in a significant number of the cases with disagreement between original, consensus and modal diagnoses, the disagreement would derive from the equivocal nature of the tumor itself. When such a factor is taken into account, the 'right' interobserver agreement level should be higher than the value of simple percentage interobserver agreement or the strength estimated by lC statistics. Taking together 71 concordant cases and 15 discordant cases with intermediate tumor nature, we estimate that at least 81% of enrolled cases were correctly diagnosed. The histological type or nuclear atypia score was erroneous in 6.5% of enrolled cases. Therefore, nuclear atypia scores which were given at individual hospitals on case entry in the NSAS-BC protocol was considered to be almost reproducible among the pathologists. It was difficult to categorize the cases with moderate percentage interobserver agreement, because multiple factors were assumed to cause interobserver disagreement in their diagnosis. Continuous efforts are needed to improve interobserver agreement and to decrease erroneous diagnosis for protocol eligibility. The benefits of the individualized pathological diagnosis system in protocol studies consist of rapid judgment of histological eligibility and early starting of adjuvant therapy. On the other hand, a major problem is in the necessity of repeating conferences or other modalities by all collaborating pathologists to improve interobserver agreement in diagnosis. Among various histological parameters, nuclear atypia is known to be the most difficult one to obtain interobserver agreement (8) (9) (10) (11) . Ideally, all pathologists participating in protocol studies should be familiar with the histological typing and nuclear grading of breast cancer in daily diagnosis. However, many pathologists are not specialized in breast pathology and cannot afford to describe histological findings in detail beyond the requirements of the general rules. In these circumstances, holding periodic slide conference sessions would be one of the most effective ways to improve interobserver agreement (5). In the NSAS-BC pathology section, the member pathologists are not always fixed; participating hospitals and personnel change. New participants may lower the agreement rate in the histological type and nuclear atypia scores, so their familiarization with the subject through participation in slide conferences can help them develop their judgment. We have had four conferences. In the second, third and fourth conferences, the original, consensus and modal diagnoses for the previous set of cases were presented again with the photomicrographs and the data were distributed as printed matter. That process was considered as a feedback system for pathologists who have diagnosed in different ways. For more efficient feedback, we are preparing other printed matter in which photomicrographs of all cases subjected to the review are shown with original, consensus and modal diagnoses. Confirmation of individual and consensus or modal diagnoses by each pathologist would be effective for improving interobserver agreement. We are also planning to compare the proportion of nuclear atypia scores 1, 2 and 3 among the collaborating hospitals, which would clarify the tendency of scoring in individual pathologists and be effective for criteria standardization.
If the number of erroneous diagnoses is large, the recurrence rate of cancer would be similar between high-and low-risk groups and result in the collapse of the quality of the protocol study. A decrease in erroneous diagnoses is major purpose of the pathology section's activity. However, the judgment that the diagnosis for a tumor was erroneous would be difficult because the patient will suffer the recurrence not in a deterministic but in a stochastic manner even if the diagnosis is judged to be correct. Especially in tumors of borderline nuclear grade, between grades 1 and 2 or between 2 and 3, the prognosis would also be intermediate.
The reproduciblity of diagnosis was maintained at a moderate K level among pathologists at individual hospitals in the NSAS-BC protocol. However, it is also difficult to judge whether the estimated rate of errors is acceptable or not for the protocol study. It would be important to monitor the prognosis of histologically high-and low-risk patients in this protocol, Jpn J Clin OncoI1999;29 (9) 419 correlate the clinical outcome with original diagnosis and compare the ideal survival curves drawn before starting patient entry and the observed survival curves. Analysis of the outcome of this protocol study will reveal whether the histological diagnosis system composed of individualized diagnoses is valid in a clinical sense.
